A detailed history of Brown Brothers Harriman & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 364,635 shares of JNJ stock, worth $53.2 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
364,635
Previous 373,245 2.31%
Holding current value
$53.2 Million
Previous $54.6 Million 8.32%
% of portfolio
0.42%
Previous 0.43%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $1.25 Million - $1.44 Million
-8,610 Reduced 2.31%
364,635 $59.1 Million
Q2 2024

Aug 09, 2024

SELL
$144.38 - $157.78 $1.21 Million - $1.32 Million
-8,357 Reduced 2.19%
373,245 $54.6 Million
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $492,668 - $516,536
-3,174 Reduced 0.82%
381,602 $60.4 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $3.1 Million - $3.38 Million
21,265 Added 5.85%
384,776 $60.3 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $7.36 Million - $8.25 Million
-47,284 Reduced 11.51%
363,511 $56.6 Million
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $4.95 Million - $5.33 Million
32,061 Added 8.47%
410,795 $68 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $4.38 Million - $5.23 Million
29,003 Added 8.29%
378,734 $58.7 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $10.7 Million - $12 Million
66,540 Added 23.5%
349,731 $61.8 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $1.58 Million - $1.76 Million
9,778 Added 3.58%
283,191 $46.3 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $395,919 - $437,867
2,354 Added 0.87%
273,413 $48.5 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $3.18 Million - $3.61 Million
-20,128 Reduced 6.91%
271,059 $48 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $2.84 Million - $3.15 Million
18,231 Added 6.68%
291,187 $49.8 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $5.59 Million - $6.21 Million
-34,609 Reduced 11.25%
272,956 $44.1 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $83,886 - $89,982
526 Added 0.17%
307,565 $50.7 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $1.9 Million - $2.12 Million
-12,427 Reduced 3.89%
307,039 $50.5 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $245,701 - $282,024
1,792 Added 0.56%
319,466 $50.3 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $802,131 - $878,984
-5,714 Reduced 1.77%
317,674 $47.3 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $1.54 Million - $1.86 Million
-11,981 Reduced 3.57%
323,388 $45.5 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $1.65 Million - $2.28 Million
-14,838 Reduced 4.24%
335,369 $44 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $1.18 Million - $1.35 Million
-9,239 Reduced 2.57%
350,207 $51.1 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $383,769 - $429,689
3,023 Added 0.85%
359,446 $46.5 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $1.09 Million - $1.19 Million
-8,283 Reduced 2.27%
356,423 $49.6 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $765,886 - $851,600
-6,092 Reduced 1.64%
364,706 $51 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $8.04 Million - $9.68 Million
65,473 Added 21.44%
370,798 $47.9 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $2.04 Million - $2.4 Million
16,799 Added 5.82%
305,325 $42.2 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $506,733 - $559,189
-4,244 Reduced 1.45%
288,526 $35 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $1.23 Million - $1.46 Million
9,859 Added 3.48%
292,770 $37.5 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $3.95 Million - $4.32 Million
-30,111 Reduced 9.62%
282,911 $39.5 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $762,189 - $796,982
-5,887 Reduced 1.85%
313,022 $40.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
318,909
318,909 $42.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.